Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Fleischer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2003
Safety and efficacy evaluation of pleconaril for treatment of the common coldRussell Fleischer, Katherine Laessig
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Nucleoside analogues and mitochondrial toxicityRussell Fleischer, Debra Boxwell, Kenneth E Sherman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 30, 2015
Ribavirin Reduces Absolute Lymphocyte Counts in Hepatitis C Virus-Infected Patients Treated With Interferon-Free, Direct-Acting Antiviral RegimensPatrick R Harrington, Russell Fleischer, Sarah M Connelly, et al.
Hepatology (Baltimore, Md.)|November 22, 2007
Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendationsKenneth E Sherman, Russell Fleischer, Katherine Laessig, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2015
Reply to Merli et alPatrick R Harrington, Russell Fleischer, Sarah M Connelly, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
Management of hepatitis B: summary of a clinical research workshopJay H Hoofnagle, Edward Doo, T Jake Liang, et al.
Hepatology (Baltimore, Md.)|April 11, 2012
Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjectsJiang Liu, Pravin R Jadhav, Shashi Amur, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2003
Safety and efficacy evaluation of pleconaril for treatment of the common coldRussell Fleischer, Katherine Laessig
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Nucleoside analogues and mitochondrial toxicityRussell Fleischer, Debra Boxwell, Kenneth E Sherman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 30, 2015
Ribavirin Reduces Absolute Lymphocyte Counts in Hepatitis C Virus-Infected Patients Treated With Interferon-Free, Direct-Acting Antiviral RegimensPatrick R Harrington, Russell Fleischer, Sarah M Connelly, et al.
Hepatology (Baltimore, Md.)|November 22, 2007
Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendationsKenneth E Sherman, Russell Fleischer, Katherine Laessig, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2015
Reply to Merli et alPatrick R Harrington, Russell Fleischer, Sarah M Connelly, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
Management of hepatitis B: summary of a clinical research workshopJay H Hoofnagle, Edward Doo, T Jake Liang, et al.
Hepatology (Baltimore, Md.)|April 11, 2012
Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjectsJiang Liu, Pravin R Jadhav, Shashi Amur, et al.
Pageof 1